Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,834 products)
- Apoptosis(6,315 products)
- Cell Cycle/Checkpoint(4,877 products)
- Chromatin/Epigenetics(2,613 products)
- Cytoskeletal Signaling(1,568 products)
- DNA Damage/DNA Repair(2,871 products)
- Endocrinology/Hormones(3,754 products)
- Enzyme(3,672 products)
- GPCR/G-Protein(9,020 products)
- Immunology and Inflammation(3,905 products)
- Influenza Virus(300 products)
- JAK/STAT signaling(415 products)
- MAPK Signaling(1,257 products)
- Membrane Transporter/Ion Channel(3,155 products)
- Metabolism(10,133 products)
- Microbiology/Virology(7,620 products)
- Neuroscience(10,473 products)
- Other Inhibitors(35,846 products)
- Oxidation-Reduction(40 products)
- PI3K/Akt/mTOR Signaling(1,429 products)
- Proteases/Proteasome(1,689 products)
- Stem Cell and Derivatives(732 products)
- Tyrosine Kinase/Adaptors(1,982 products)
- Ubiquitination(1,726 products)
Show 16 more subcategories
Found 66515 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
LpxC-IN-10
CAS:LpxC-IN-10 is a selective LpxC inhibitor with an MIC of 0.5 μg/mL against E. coli and K. pneumoniae and is capable of being used to study bacterial infections.Formula:C30H31N5O3Color and Shape:SolidMolecular weight:509.6Antifungal agent 27
Antifungal agent 27 shows moderate action against MRSA, weak against C. albicans, with MICs of 8 μg/mL and 32 μg/mL, respectively.Formula:C18H23N5OSColor and Shape:SolidMolecular weight:357.47AChE/BACE1/GSK3β-IN-1
AChE/BACE1/GSK3β-IN-1 is an orally active, blood-brain barrier-transparent, moderately bioavailable triple inhibitor of AChE/BACE1/GSK3β.Formula:C26H27FN2O4Color and Shape:SolidMolecular weight:450.5NRX-2663
CAS:NRX-2663 boosts β-catenin binding to E3 ligase SCFβ-TrCP (Kd: 54.8 nM, EC50: 22.9 nM).Formula:C20H13F3N2O5Color and Shape:SolidMolecular weight:418.32Bleomycin Free Base
CAS:Bleomycin Free Base, a glycopeptide antibiotic, halts DNA function and treats solid tumors.Formula:C55H84N17O21S3Color and Shape:SolidMolecular weight:1415.55CDK9-IN-11
CAS:CDK9-IN-11 is a potent CDK9 inhibitor that is the ligand for the PROTAC CDK9 Degrader-1 [1].Formula:C20H25N3O4Purity:98%Color and Shape:SolidMolecular weight:371.43Zalunfiban dihydrochloride
Zalunfiban (RUC-4) is a potent αIIbβ3 platelet antagonist, IC50 45 nM, used in myocardial infarction research.Formula:C16H20Cl2N8O2SColor and Shape:SolidMolecular weight:459.35CRS-3123
CAS:CRS-3123, a methionyl-tRNA synthetase inhibitor, is used potentially for the treatment of enteric infections.Formula:C19H19Br2N3O2SPurity:98%Color and Shape:SolidMolecular weight:513.25NCATS-SM4487
CAS:NCATS-SM4487 is a highly selective inhibitor of GALK1 (IC50: 0.05 μM).Formula:C25H24ClFN8O2Color and Shape:SolidMolecular weight:522.96MK2-IN-4
CAS:MK2-IN-4 is a MAPKAPK2 (MK2) inhibitor (IC50: 45 nM). MK2-IN-4 can be used in cancer, inflammation and immunology studies.Formula:C25H24N4O2Color and Shape:SolidMolecular weight:412.48BMS-751324
CAS:BMS-751324: p38α MAPK inhibitor with carbamyl-methyl, esters, phosphate from HPA. Reduces rat arthritis swelling and TNFα.Formula:C32H35N6O10PColor and Shape:SolidMolecular weight:694.63cis-4-Br-2,5-F2-PCPA
cis-4-Br-2,5-F2-PCPA (S1024) blocks LSD1/LSD2 (Ki: 94 nM/8.4 μM), hinders cancer stem cell growth, raises H3K4me2 in CCRF-CEM cells.Formula:C9H8BrF2NColor and Shape:SolidMolecular weight:248.07FLT3-IN-13
FLT3-IN-13 inhibits topoisomerase II/FLT3 in leukemia with IC50 of 2.26 μM, causes G2/M arrest, and promotes apoptosis.Formula:C20H14N4O2Color and Shape:SolidMolecular weight:342.35ERK-IN-2
CAS:ERK-IN-2, an ERK2 inhibitor, exhibits an IC50 value of 1.8 nM. At doses greater than 10 μM, it may induce off-target toxicity and/or activity [1].Formula:C16H18ClN5O2Purity:98%Color and Shape:SolidMolecular weight:347.80LRRK2-IN-5
LRRK2-IN-5 is an oral, BBB-penetrating selective inhibitor for LRRK2 with IC50s: 1.2μM (GS) and 16μM (WT); halts LRRK2 autophosphorylation.Formula:C24H26F2N4O2SColor and Shape:SolidMolecular weight:472.55hCAII-IN-3
hCAII-IN-3 inhibits key hCA isoforms with Ki: hCA I (403.8 nM), hCA II (5.1 nM), hCA IX (10.2 nM), hCA XII (5.2 nM); shows anticancer potential.Formula:C17H21N3O3SColor and Shape:SolidMolecular weight:347.43UTPγS trisodium salt
CAS:P2Y2 and P2Y4 receptor agonistFormula:C9H12N2Na3O14P3SPurity:98%Color and Shape:SolidMolecular weight:566.15KRAS G12C inhibitor 56
CAS:KRAS G12C inhibitor 56, a powerful inhibitor of SOS1 with an inhibitory concentration (IC50) of 1.6 nM, holds promise for use in cancer research.Formula:C32H39N7O4SColor and Shape:SolidMolecular weight:617.769(R)-HETE
CAS:9(R)-HETE, 50% of racemic mix, activates RXRγ 1.5x at 300 nM; identified by HPLC comparison.Formula:C20H32O3Color and Shape:SolidMolecular weight:320.47MS8815
CAS:MS8815 is a selective EZH2 PROTAC degrader with IC50 of 8.6 nM, used in triple-negative breast cancer research.Formula:C65H87N9O8SColor and Shape:SolidMolecular weight:1154.51
